Entity Common Stock, Shares Outstanding of INTERCEPT PHARMACEUTICALS, INC. from 12 Nov 2012 to 02 Nov 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
INTERCEPT PHARMACEUTICALS, INC. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 12 Nov 2012 to 02 Nov 2023.
  • INTERCEPT PHARMACEUTICALS, INC. Entity Common Stock, Shares Outstanding for the quarter ending 02 Nov 2023 was 41,825,966, a 0.99% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

INTERCEPT PHARMACEUTICALS, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2023 41,825,966 +408,839 +0.99% 02 Nov 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 41,782,727 +11,984,687 +40% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 41,687,084 +11,978,238 +40% 31 Mar 2023 10-Q 27 Apr 2023 2023 Q1
Q4 2022 41,670,120 +11,977,528 +40% 31 Jan 2023 10-K 02 Mar 2023 2022 FY
Q3 2022 41,417,127 +11,870,153 +40% 30 Sep 2022 10-Q 01 Nov 2022 2022 Q3
Q2 2022 29,798,040 -3,403,141 -10% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 29,708,846 -3,445,261 -10% 31 Mar 2022 10-Q 06 May 2022 2022 Q1
Q4 2021 29,692,592 -3,323,022 -10% 31 Jan 2022 10-K 02 Mar 2022 2021 FY
Q3 2021 29,546,974 -3,445,462 -10% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 33,201,181 +220,377 +0.67% 30 Jun 2021 10-Q 29 Jul 2021 2021 Q2
Q1 2021 33,154,107 +216,676 +0.66% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 33,015,614 +162,548 +0.5% 31 Dec 2020 10-K 25 Feb 2021 2020 FY
Q3 2020 32,992,436 +258,989 +0.79% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 32,980,804 +284,420 +0.87% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 32,937,431 +3,160,353 +11% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 32,853,066 +3,159,190 +11% 31 Dec 2019 10-K 25 Feb 2020 2019 FY
Q3 2019 32,733,447 +3,078,979 +10% 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 32,696,384 +3,131,700 +11% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 29,777,078 +4,445,270 +18% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 29,693,876 +4,521,198 +18% 31 Dec 2018 10-K 01 Mar 2019 2018 FY
Q3 2018 29,654,468 +4,552,389 +18% 30 Sep 2018 10-Q 01 Nov 2018 2018 Q3
Q2 2018 29,564,684 +4,464,763 +18% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 25,331,808 +322,630 +1.3% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 25,172,678 +341,207 +1.4% 31 Dec 2017 10-K 28 Feb 2018 2017 FY
Q3 2017 25,102,079 +293,302 +1.2% 30 Sep 2017 10-Q 06 Nov 2017 2017 Q3
Q2 2017 25,099,921 +373,545 +1.5% 30 Jun 2017 10-Q 03 Aug 2017 2017 Q2
Q1 2017 25,009,178 +413,908 +1.7% 28 Apr 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 24,831,471 +425,494 +1.7% 31 Jan 2017 10-K 01 Mar 2017 2016 FY
Q3 2016 24,808,777 +477,251 +2% 31 Oct 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 24,726,376 +524,211 +2.2% 31 Jul 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 24,595,270 +522,959 +2.2% 15 Apr 2016 10-Q 10 May 2016 2016 Q1
Q4 2015 24,405,977 31 Jan 2016 10-K 29 Feb 2016 2015 FY
Q3 2015 24,331,526 +2,971,849 +14% 31 Oct 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 24,202,165 +2,984,206 +14% 15 Jul 2015 10-Q 07 Aug 2015 2015 Q2
Q1 2015 24,072,311 +2,984,954 +14% 30 Apr 2015 10-Q 11 May 2015 2015 Q1
Q3 2014 21,359,677 +2,024,101 +10% 31 Oct 2014 10-Q 06 Nov 2014 2014 Q3
Q2 2014 21,217,959 +2,036,537 +11% 31 Jul 2014 10-Q 11 Aug 2014 2014 Q2
Q1 2014 21,087,357 +4,473,192 +27% 30 Apr 2014 10-Q 09 May 2014 2014 Q1
Q3 2013 19,335,576 +2,823,359 +17% 31 Oct 2013 10-Q 14 Nov 2013 2013 Q3
Q2 2013 19,181,422 01 Aug 2013 10-Q 13 Aug 2013 2013 Q2
Q1 2013 16,614,165 15 Mar 2013 10-K 01 Apr 2013 2012 FY
Q3 2012 16,512,217 12 Nov 2012 10-Q/A 21 Dec 2012 2012 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.